Sitemap www.ardena.com

Pages

• About Us
  • Ardena Management Team
  • Mission, vision & values
  • Our approach
  • History
• Careers
  • Testimonials
    • Ana
    • Maxime
    • Raja
    • Stijn
  • Vacancies
  • Why join Ardena?
• Contact Us
• COVID-19 Solutions
• Drug Product
  Development & Manufacturing
  • Services
    • Drug Product Formulation Development
      • Lipid based formulations
      • Nanosuspensions
      • Solid dispersions
    • Drug Product Analytical Development & QC
      • Chromatographic methods
      • Dissolution methods
    • Drug Product Stability Studies
    • Drug Product Manufacturing
  • Highlights
  • Capabilities
• Drug Substance
  Development & Manufacturing
  • Services
    • Drug Substance Characterization
      • Molecular properties
      • Molecular structure confirmation
      • Powder properties
      • Solid state properties
    • Drug Substance Process Development
      • Route scouting
      • Crystallization process development
      • Process scale up
    • Drug Substance Analytical Development & QC
    • Drug Substance Stability Studies
    • Drug Substance Manufacturing
    • Solid State Research
      • Crystal structure by X-Ray
      • Solid form screening
      • Solid form selection
      • IP support
  • Highlights
  • Capabilities
• General Terms and Conditions
• Home
• Legal entities Ardena
• Nanomedicine
• News & Insights
• Privacy Policy
• Registration form
• Sitemap www.ardena.com
• Upcoming events
• Webinar Archives
• Clinical Logistics
  • Services
    • Packaging, Labelling & Clinical trial supply
    • Biosample collection kits, Logistics & Biorepository
  • Highlights
  • Capabilities
• Bioanalysis
  • Services
    • Discovery Support
    • Preclinical Bioanalysis
    • Clinical Bioanalysis
    • Biomarkers
  • Highlights
  • Capabilities
• Dossier Development
  • Services
    • Scientific Report Writing
    • Quality Document Writing
    • Regulatory Dossier Writing
    • Submission and Liaison
  • Highlights
  • Capabilities

Posts by category

• Category: Events
• Category: Insights
  • EMA and FDA have activated plans to fast track the development and approval of therapeutics against COVID-19.
  • EMA extends nitrosamine risk assessments to investigational drugs
  • EMA request for Nitrosamine Risk Assessment
• Category: News
  • CVC Credit Partners refinances Ardena’s credit facilities
  • Ardena Assen is doubling its capacity – Update 25.03.2020
  • GHO Capital acquires Ardena
  • Ardena Assen is doubling its capacity
  • BVA award nominee
  • Ardena launches Life Science Ingredients Arm
  • Ardena launches bimonthly newsletter
  • Ardena cements growth and expansion with new HQ
  • Ardena expands nanomedicine capabilities
  • Ardena acquires Syntagon and strengthens API offering
  • Ardena acquires ChemConnection adding API expertise
  • Ardena is expanding its Belgian site
  • ABL acquisition extends early-phase offering
  • Ardena launches following Pharmavize and Crystallics merger
  • Category: Newsletter
    • Scientific Advice and Dialogue with EMA during Drug Development
    • Oligonucleotide therapeutics: How to measure plasma concentration, tissue distribution and immunogenicity?
    • Powder blending in early-phase drug product development: Balancing art and science
    • How to obtain enantiopure drug substance through crystallization?
    • How to enhance the safety of your drug substance synthesis process by smart chemical design?
    • Ardena launches integrated drug discovery support services
    • How to save significantly on early-phase clinical supply logistics?
    • Which solubility-enhancing technology should I use to support my early drug development project?
    • What is an acceptable impurity level for a drug substance used in GLP toxicology studies?
    • When to conduct a polymorph screening?

Careers

• Commercial finance controller
• Quality Assurance Officer
• Production Operator
• Internship - digital marketeer
• Head of People
• Validation Engineer
• Technician/Associate Scientist
• Group leader formulation and production
• Drug Product Formulation Scientist
• Technician LC-MS/MS
• BSc/MSc in Analytical Chemistry

Testimonials

• Stijn
• Raja
• Maxime
• Ana